PALATINE, IL -- (Marketwired) -- 07/26/13 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating , today announced that the company plans to report financial results for the second quarter of 2013 following the close of financial markets on Thursday, August 1, ...
↧